Front Row Advisors LLC Novo Nordisk A S Transaction History

Front Row Advisors LLC

$271 Million
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$122.71 - $146.91 $245 - $293	2 Added 0.87%	231 $32,000
Q1 2024 May 14, 2024	BUY	$102.11 - $135.92 $23,383 - $31,125	229 New	229 $29,000
Q3 2023 Nov 15, 2023	BUY	$90.94 - $199.54 $15,005 - $32,924	165 Added 217.11%	241 $21,000
Q2 2023 Aug 14, 2023	SELL	$155.98 - $172.65 $1,247 - $1,381	-8 Reduced 9.52%	76 $12,000
Q1 2023 May 22, 2023	BUY	$132.34 - $159.14 $9,396 - $11,298	71 Added 546.15%	84 $13,000
Q1 2023 May 15, 2023	SELL	$132.34 - $159.14 $9,660 - $11,617	-73 Reduced 84.88%	13 $8,000
Q4 2022 Feb 15, 2023	SELL	$102.55 - $135.33 $3,999 - $5,277	-39 Reduced 31.2%	86 $12,000
Q3 2022 Nov 15, 2022	SELL	$95.28 - $116.93 $2,286 - $2,806	-24 Reduced 16.11%	125 $13,000
Q2 2022 Aug 15, 2022	SELL	$103.24 - $121.81 $206 - $243	-2 Reduced 1.32%	149 $17,000
Q1 2022 May 11, 2022	SELL	$93.1 - $112.54 $3,724 - $4,501	-40 Reduced 20.94%	151 $16,000
Q4 2021 Mar 09, 2022	SELL	$95.88 - $117.08 $95 - $117	-1 Reduced 0.52%	191 $21,000
Q3 2021 Nov 03, 2021	SELL	$84.42 - $106.62 $168 - $213	-2 Reduced 1.03%	192 $18,000
Q2 2021 Aug 23, 2021	BUY	$67.66 - $84.76 $608 - $762	9 Added 4.86%	194 $20,000
Q1 2021 Apr 28, 2021	BUY	$67.06 - $75.82 $268 - $303	4 Added 2.21%	185 $13,000
Q4 2020 Feb 25, 2021	SELL	$63.89 - $73.8 $511 - $590	-8 Reduced 4.23%	181 $13,000
Q3 2020 Nov 30, 2020	BUY	$63.69 - $70.22 $12,037 - $13,271	189 New	189 $13,000
Q1 2020 May 08, 2020	SELL	$49.46 - $64.78 $2,176 - $2,850	-44 Closed	0 $0
Q3 2019 Nov 08, 2019	SELL	$47.54 - $53.43 $2,091 - $2,350	-44 Reduced 50.0%	44 $2,000
Q1 2019 May 17, 2019	SELL	$46.36 - $52.63 $4,450 - $5,052	-96 Reduced 52.17%	88 $5,000
Q4 2018 Feb 13, 2019	SELL	$41.54 - $47.25 $913 - $1,039	-22 Reduced 10.68%	184 $8,000
Q3 2018 Nov 13, 2018	SELL	$46.76 - $51.24 $4,535 - $4,970	-97 Reduced 32.01%	206 $9,000
Q2 2018 Jul 31, 2018	BUY	$44.29 - $50.42 $4,251 - $4,840	96 Added 46.38%	303 $15,000
Q1 2018 May 21, 2018	BUY	$48.49 - $58.14 $7,661 - $9,186	158 Added 322.45%	207 $10,000
Q4 2017 Feb 01, 2018	BUY	$47.53 - $53.73 $2,328 - $2,632	49	49 $3,000

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

Jennison Associates LLC

20.2M
Shares

$1.76 Billion
1.5% of portfolio
Morgan Stanley New York, NY

14.4M
Shares

$1.26 Billion
0.13% of portfolio
Bank Of America Corp Charlotte, NC

14.3M
Shares

$1.25 Billion
0.14% of portfolio
Ken Fisher Fisher Asset Management, LLC | Camas, Wa

13.3M
Shares

$1.16 Billion
0.65% of portfolio
Fayez Sarofim & CO Houston, TX

12.2M
Shares

$1.07 Billion
3.76% of portfolio

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Front Row Advisors LLC with notifications on news.

Account